Establishment Labs Q1 Earnings Call Highlights
Key takeaways
- U.S. ramp and minimally invasive momentum: U.S. revenue surged to $19.6 million (up 216% YoY) as the company surpassed 1,700 U.S. accounts; the Preservé minimally invasive platform, launched in the U.S.
- Refinancing and path to cash-flow positivity: Cash fell to $68.1 million after U.S.
- Interested in Establishment Labs Holdings Inc.?
Establishment Labs Q1 Earnings Call Highlights Market Beat Wed, May 6, 2026 at 10:54 PM GMT+7 8 min read ESTA Establishment Labs logo Key Points Strong Q1 results and raised outlook: Establishment Labs reported Q1 revenue of $59.9 million and adjusted EBITDA of $1.2 million (third consecutive quarter of positive adjusted EBITDA), with revenue up 45% year-over-year and management raising full-year 2026 revenue guidance to $266.5–$268.5 million (≈26–27% growth).
U.S. ramp and minimally invasive momentum: U.S. revenue surged to $19.6 million (up 216% YoY) as the company surpassed 1,700 U.S. accounts; the Preservé minimally invasive platform, launched in the U.S. in March, generated $9.1 million in Q1 and management now expects minimally invasive revenue to exceed $35 million in 2026.
Refinancing and path to cash-flow positivity: Cash fell to $68.1 million after U.S. investments, the credit facility was increased to $265 million at an 8.75% rate with PIK options, and management expects to reach cash-flow positive in the second half of 2026 without the need for equity financing.